Patterns of Neural Network Functional Connectivity Associated With Mania/Hypomania and Depression Risk in 3 Independent Young Adult Samples.
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
medline:
1
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
aheadofprint
Résumé
Mania/hypomania is the pathognomonic feature of bipolar disorder (BD). Established, reliable neural markers denoting mania/hypomania risk to help with early risk detection and diagnosis and guide the targeting of pathophysiologically informed interventions are lacking. To identify patterns of neural responses associated with lifetime mania/hypomania risk, the specificity of such neural responses to mania/hypomania risk vs depression risk, and the extent of replication of findings in 2 independent test samples. This cross-sectional study included 3 independent samples of young adults aged 18 to 30 years without BD or active substance use disorder within the past 3 months who were recruited from the community through advertising. Of 603 approached, 299 were ultimately included and underwent functional magnetic resonance imaging at the University of Pittsburgh, Pittsburgh, Pennsylvania, from July 2014 to May 2023. Activity and functional connectivity to approach-related emotions were examined using a region-of-interest mask supporting emotion processing and emotional regulation. The Mood Spectrum Self-Report assessed lifetime mania/hypomania risk and depression risk. In the discovery sample, elastic net regression models identified neural variables associated with mania/hypomania and depression risk; multivariable regression models identified the extent to which selected variables were significantly associated with each risk measure. Multivariable regression models then determined whether associations in the discovery sample replicated in both test samples. A total of 299 participants were included. The discovery sample included 114 individuals (mean [SD] age, 21.60 [1.91] years; 80 female and 34 male); test sample 1, 103 individuals (mean [SD] age, 21.57 [2.09] years; 30 male and 73 female); and test sample 2, 82 individuals (mean [SD] age, 23.43 [2.86] years; 48 female, 29 male, and 5 nonbinary). Associations between neuroimaging variables and Mood Spectrum Self-Report measures were consistent across all 3 samples. Bilateral amygdala-left amygdala functional connectivity and bilateral ventrolateral prefrontal cortex-right dorsolateral prefrontal cortex functional connectivity were positively associated with mania/hypomania risk: discovery omnibus χ2 = 1671.7 (P < .001); test sample 1 omnibus χ2 = 1790.6 (P < .001); test sample 2 omnibus χ2 = 632.7 (P < .001). Bilateral amygdala-left amygdala functional connectivity and right caudate activity were positively associated and negatively associated with depression risk, respectively: discovery omnibus χ2 = 2566.2 (P < .001); test sample 1 omnibus χ2 = 2935.9 (P < .001); test sample 2 omnibus χ2 = 1004.5 (P < .001). In this study of young adults, greater interamygdala functional connectivity was associated with greater risk of both mania/hypomania and depression. By contrast, greater functional connectivity between ventral attention or salience and central executive networks and greater caudate deactivation were reliably associated with greater risk of mania/hypomania and depression, respectively. These replicated findings indicate promising neural markers distinguishing mania/hypomania-specific risk from depression-specific risk and may provide neural targets to guide and monitor interventions for mania/hypomania and depression in at-risk individuals.
Identifiants
pubmed: 37910117
pii: 2811149
doi: 10.1001/jamapsychiatry.2023.4150
pmc: PMC10620679
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Psychother Psychosom. 2021;90(6):365-372
pubmed: 34350890
J Affect Disord. 2021 Sep 1;292:9-20
pubmed: 34087634
Nature. 2022 Mar;603(7902):654-660
pubmed: 35296861
Clin Psychol Rev. 2008 Oct;28(7):1188-205
pubmed: 18565633
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Aug;4(8):726-733
pubmed: 31201147
Biol Psychiatry. 2013 Jan 15;73(2):111-8
pubmed: 22784485
Neuropsychologia. 2011 Aug;49(10):2825-35
pubmed: 21703286
Front Syst Neurosci. 2016 Dec 27;10:104
pubmed: 28082874
Annu Rev Clin Psychol. 2012;8:243-67
pubmed: 22077912
Brain Behav. 2021 Jan;11(1):e01953
pubmed: 33210461
Cell Rep. 2019 Oct 1;29(1):34-48.e4
pubmed: 31577954
J Cereb Blood Flow Metab. 1998 Aug;18(8):896-905
pubmed: 9701351
J Pers Soc Psychol. 2002 Apr;82(4):610-8
pubmed: 11999927
Neuropsychopharmacology. 2021 Jun;46(7):1340-1347
pubmed: 33782511
Elife. 2022 May 05;11:
pubmed: 35510840
Neuroimage. 2004 Feb;21(2):674-86
pubmed: 14980569
Front Hum Neurosci. 2013 Nov 07;7:746
pubmed: 24223546
Mol Psychiatry. 2023 Jul;28(7):2826-2838
pubmed: 36782061
Bipolar Disord. 2015 May;17(3):315-22
pubmed: 25295997
J Affect Disord. 2016 Jan 15;190:483-493
pubmed: 26551408
Neuroimage. 2016 Jun;133:98-110
pubmed: 26926791
Biol Psychiatry. 2005 Mar 15;57(6):624-32
pubmed: 15780849
Transl Psychiatry. 2022 Apr 5;12(1):143
pubmed: 35383150
Bipolar Disord. 2018 Dec;20(8):697-707
pubmed: 30294823
Bipolar Disord. 2012 May;14(3):249-60
pubmed: 22548898
J Affect Disord. 2014 Jan;152-154:83-90
pubmed: 23948633
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Eur Psychiatry. 2022 May 31;65(1):e30
pubmed: 35638732
Hum Brain Mapp. 2016 Feb;37(2):808-18
pubmed: 26611711
J Affect Disord. 2023 Apr 1;326:96-104
pubmed: 36717032
Curr Psychiatry Rep. 2015 Aug;17(8):604
pubmed: 26084666
Bipolar Disord. 2013 Dec;15(8):839-854
pubmed: 24148027
Neuroimage. 2012 Jul 16;61(4):1277-86
pubmed: 22484411
Cereb Cortex. 2016 Mar;26(3):933-942
pubmed: 25331601
Epidemiol Psychiatr Sci. 2020 Sep 08;29:e166
pubmed: 32895076
Bipolar Disord. 2007 Nov;9(7):698-705
pubmed: 17988359
Hum Brain Mapp. 2014 Jul;35(7):2995-3007
pubmed: 24038516
Am J Psychiatry. 2013 May;170(5):533-41
pubmed: 23558337
Mol Psychiatry. 2022 Aug;27(8):3129-3137
pubmed: 35697759
PLoS One. 2012;7(10):e46833
pubmed: 23056477
Am Psychol. 2015 Sep;70(6):487-98
pubmed: 26348332
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 May;1(3):288-298
pubmed: 27453953
Emotion. 2008 Feb;8(1):23-33
pubmed: 18266513
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Psychiatr Serv. 2001 Jan;52(1):51-5
pubmed: 11141528
Annu Rev Neurosci. 2015 Jul 8;38:433-47
pubmed: 25938726
Brain. 2015 Sep;138(Pt 9):2777-90
pubmed: 26112339
J Affect Disord. 2023 Jun 15;331:238-244
pubmed: 36931569
Mol Psychiatry. 2023 Mar;28(3):1046-1056
pubmed: 36481935
Int J Bipolar Disord. 2021 Jun 25;9(1):21
pubmed: 34170440
Am J Psychiatry. 2014 Aug;171(8):829-43
pubmed: 24626773
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jul;5(7):660-668
pubmed: 31862347
J Pers Assess. 2009 Mar;91(2):121-36
pubmed: 19205933
Neurosci Biobehav Rev. 2015 Sep;56:330-44
pubmed: 26234819
Dev Cogn Neurosci. 2013 Jul;5:185-96
pubmed: 23590840
Dev Psychopathol. 2020 Dec;32(5):1579-1596
pubmed: 33427167
Neurosci Biobehav Rev. 2020 Nov;118:358-366
pubmed: 32739421
J Clin Psychiatry. 2012 Jan;73(1):22-8
pubmed: 22316575
Compr Psychiatry. 2002 Jan-Feb;43(1):69-73
pubmed: 11788923
Bipolar Disord. 2022 Aug;24(5):474-498
pubmed: 35060259
J Am Acad Child Adolesc Psychiatry. 2011 Dec;50(12):1275-89.e2
pubmed: 22115148